Search results
Is Eli Lilly Stock A Buy On A Recent Crohn's Disease-Related Rally?
Investor's Business Daily· 5 days agoZepbound is projected to generate $4.35 billion in sales. In 2029, analysts expect the two drugs to...
Dow tumbles 300 points, S&P 500 declines as little outside of Nvidia is working: Live updates
CNBC· 7 days agoStocks slid Wednesday as rocky trading in artificial intelligence darling Nvidia threatened one of...
1 Stock to Buy, 1 Stock to Sell This Week: Nvidia, Dollar Tree | Investing.com Canada
Investing.com· 2 days agoU.S. stocks closed mostly higher on Friday, with the Dow Jones Industrial Average scoring its best...
‘Star Wars’ Prequel ‘The Acolyte’ Is a $180M Waste of Time
The Daily Beast· 1 hour agoThe latest tale in the galaxy far, far away is set a century before Star Wars: Episode 1—The Phantom...
S&P 500 Valuations Are Nuts. Why People Are Still Buying.
Barrons.com· 20 hours agoThat’s a more blunt way of saying equities are overvalued. This means they’re at risk of getting...
Summit Therapeutics' stock surges as lung-cancer treatment vies with Merck's blockbuster
Morningstar· 5 days agoShares of Summit Therapeutics Inc. (SMMT) jumped more than 270% Thursday after the company said its experimental cancer drug outperformed Merck & Co. Inc.'s blockbuster Keytruda ...
Leonard Schleifer
Fortune· 5 hours agoToday its monoclonal antibodies, particularly Eylea for retinal diseases, are producing major cash injections for the company. Indeed, Eylea is on track for mega-blockbuster
1 Stock to Buy, 1 Stock to Sell This Week: Nvidia, Dollar Tree | Investing.com AU
Investing.com· 2 days agoU.S. stocks closed mostly higher on Friday, with the Dow Jones Industrial Average scoring its best...
Prediction: These Could Be the Best-Performing Pharmaceutical Stocks Through 2030
Motley Fool via Yahoo Finance· 2 days agoEli Lilly could soon earn approval for an Alzheimer's disease (AD) therapy that could be a ...
Rising Star race blown wide open; Carlton's golden ticket found?
ESPN· 2 days agoIn Round 12 of the 2024 AFL season, a Carlton tall showed his value as a solo ruck and Marcus...
